Hereditary tyrosinemia type 1 metabolites impair DNA excision repair pathways

被引：15
|
作者：
van Dyk, E. [1 ]
Steenkamp, A. [1 ]
Koekemoer, G. [2 ]
Pretorius, P. J. [1 ]
机构：
[1] North West Univ, Sch Phys & Chem Sci, Ctr Human Metabon, ZA-2520 Potchefstroom, South Africa
[2] North West Univ, Stat Consultat Serv, ZA-2520 Potchefstroom, South Africa
来源：
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | 2010年 / 401卷 / 01期
基金：
新加坡国家研究基金会;
关键词：
Hereditary tyrosinemia; Base excision repair; Nucleotide excision repair; Comet assay; COMET ASSAY; DAMAGE; FUMARYLACETOACETATE; HOGG1;
D O I：
10.1016/j.bbrc.2010.09.002
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Hereditary tyrosinemia type 1 is an autosomal recessive metabolic disorder, which is caused by a defective fumarylacetoacetate hydrolase enzyme, and consequently metabolites such as succinylacetone and p-hydroxyphenylpyruvate accumulate. We used a modified comet assay to determine the effect of these metabolites on base- and nucleotide excision repair pathways. Our results indicate that the metabolites affected the repair mechanisms differently, since the metabolites had a bigger detrimental effect on BER than on NER. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码：32 / 36
页数：5
相关论文
共 50 条
  • [21] An interplay of the base excision repair and mismatch repair pathways in active DNA demethylation
    Grin, Inga
    Ishchenko, Alexander A.
    NUCLEIC ACIDS RESEARCH, 2016, 44 (08) : 3713 - 3727
  • [22] DNA repair fidelity of base excision repair pathways in human cell extracts
    Zhang, QM
    Dianov, GL
    DNA REPAIR, 2005, 4 (02) : 263 - 270
  • [23] p53 regulation of DNA excision repair pathways
    Smith, ML
    Seo, YR
    MUTAGENESIS, 2002, 17 (02) : 149 - 156
  • [24] Detection of hereditary tyrosinemia type 1 (HT1) by restriction analysis of PCR amplified genomic DNA.
    Schranz, DB
    Jack, R
    Scott, CR
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2001, 116 (02) : 294 - 294
  • [25] A patient with urinary succinylacetone-negative hereditary tyrosinemia type 1
    Mori, Jun
    Furukawa, Taizo
    Kodo, Kazuki
    Nakajima, Hisakazu
    Yuasa, Miori
    Kubota, Mitsuru
    Shigematsu, Yosuke
    PEDIATRICS INTERNATIONAL, 2023, 65 (01)
  • [26] Liver Transplant for Children With Hepatocellular Carcinoma and Hereditary Tyrosinemia Type 1
    Bahador, Ali
    Dehghani, Seyed Mohsen
    Geramizadeh, Bita
    Nikeghbalian, Saman
    Bahador, Mohsen
    Malekhosseini, Seyed Ali
    Kazemi, Kurosh
    Salahi, Heshmatolah
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2015, 13 (04) : 329 - 332
  • [27] Revisiting hereditary tyrosinemia Type 1-spectrum of radiological findings
    Shaikh, Sana
    Qureshi, Asma
    Faiq, Syed Mohammad
    BJR CASE REPORTS, 2019, 5 (02):
  • [28] Evaluation of dichloroacetate treatment in a murine model of hereditary tyrosinemia type 1
    Langlois, Chantale
    Jorquera, Rossana
    Finegold, Milton
    Shroads, Albert L.
    Stacpoole, Peter W.
    Tanguay, Robert M.
    BIOCHEMICAL PHARMACOLOGY, 2006, 71 (11) : 1648 - 1661
  • [29] siRNA Treatment for Hereditary Tyrosinemia Type I (HT1)
    Barzi, Mercedes
    Chen, Tong
    Hemmingsen, Madeline
    He, Gordon
    Keibler, Mark
    Sichani, Azadeh
    Garfinkel, Benny
    Bissig, Karl-Dimiter
    MOLECULAR THERAPY, 2023, 31 (04) : 284 - 284
  • [30] Imaging features of type 1 hereditary tyrosinemia: A review of 30 patients
    Dubois, J
    Garel, L
    Patriquin, H
    Paradis, K
    Forget, S
    Filiatrault, D
    Grignon, A
    Russo, P
    StVil, D
    PEDIATRIC RADIOLOGY, 1996, 26 (12) : 845 - 851
12345